Tarenflurbil | m-entrepreneurship.com

Product Name :
Tarenflurbil

Search keywords :
Tarenflurbil

drugId :
null

Target Vo:
Nuclear factor NF-kappa-B complex

Target Vo Short Name :
NF-κB

Moa_Name:
Nuclear factor NF-kappa-B complex inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Loma Linda University

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Alzheimer Disease

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PRMT1 (Y10P72) Mouse mAb Technical Information
Isatuximab (anti-CD38) MedChemExpress
TriMethyl-Histone H3 (Lys27) Antibody: TriMethyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to TriMethyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts